Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrizio Maggi

Showing results (11-20 of 361) with videos related to

Pageof 37
Sort By:
Viruses|November 11, 2022
Do We Really Need Omicron Spike-Based Updated COVID-19 Vaccines? Evidence and PipelineDaniele Focosi, Fabrizio Maggi
International Journal of Molecular Sciences|February 11, 2023
SARS-CoV-2: Advances in Serological Methods and the Understanding of Antibody EscapeDaniele Focosi, Fabrizio Maggi
Human Vaccines & Immunotherapeutics|October 6, 2023
Respiratory delivery of passive immunotherapies for SARS-CoV-2 prophylaxis and therapyDaniele Focosi, Fabrizio Maggi
Viruses|May 27, 2023
Second-Generation SARS-CoV-2 Recombinants: Lessons from Other VirusesDaniele Focosi, Fabrizio Maggi
Viruses|March 30, 2023
How SARS-CoV-2 Big Data Are Challenging Viral Taxonomy RulesDaniele Focosi, Fabrizio Maggi
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 7, 2016
Zika Virus: Implications for Public HealthDaniele Focosi, Fabrizio Maggi, Mauro Pistello
Current Medicinal Chemistry|October 7, 2017
Virome and Inflammasomes, a Finely Tuned Balance with Important Consequences for the Host HealthGiulia Freer, Fabrizio Maggi, Mauro Pistello
Human Vaccines & Immunotherapeutics|May 5, 2021
Is a single COVID-19 vaccine dose enough in convalescents ?Daniele Focosi, Andreina Baj, Fabrizio Maggi
Influenza and Other Respiratory Viruses|May 6, 2025
An Overview of the H5N1 mRNA Vaccine PipelineDaniele Focosi, Emanuele Nicastri, Fabrizio Maggi
Annals of Translational Medicine|February 5, 2020
Checkpoint inhibitors and progressive multifocal leukoencephalopathy: friends of foes?Daniele Focosi, Marco Tuccori, Fabrizio Maggi
Pageof 37

Showing results (11-20 of 361) with videos related to

Sort By:
Pageof 37
Viruses|November 11, 2022
Do We Really Need Omicron Spike-Based Updated COVID-19 Vaccines? Evidence and PipelineDaniele Focosi, Fabrizio Maggi
International Journal of Molecular Sciences|February 11, 2023
SARS-CoV-2: Advances in Serological Methods and the Understanding of Antibody EscapeDaniele Focosi, Fabrizio Maggi
Human Vaccines & Immunotherapeutics|October 6, 2023
Respiratory delivery of passive immunotherapies for SARS-CoV-2 prophylaxis and therapyDaniele Focosi, Fabrizio Maggi
Viruses|May 27, 2023
Second-Generation SARS-CoV-2 Recombinants: Lessons from Other VirusesDaniele Focosi, Fabrizio Maggi
Viruses|March 30, 2023
How SARS-CoV-2 Big Data Are Challenging Viral Taxonomy RulesDaniele Focosi, Fabrizio Maggi
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 7, 2016
Zika Virus: Implications for Public HealthDaniele Focosi, Fabrizio Maggi, Mauro Pistello
Current Medicinal Chemistry|October 7, 2017
Virome and Inflammasomes, a Finely Tuned Balance with Important Consequences for the Host HealthGiulia Freer, Fabrizio Maggi, Mauro Pistello
Human Vaccines & Immunotherapeutics|May 5, 2021
Is a single COVID-19 vaccine dose enough in convalescents ?Daniele Focosi, Andreina Baj, Fabrizio Maggi
Influenza and Other Respiratory Viruses|May 6, 2025
An Overview of the H5N1 mRNA Vaccine PipelineDaniele Focosi, Emanuele Nicastri, Fabrizio Maggi
Annals of Translational Medicine|February 5, 2020
Checkpoint inhibitors and progressive multifocal leukoencephalopathy: friends of foes?Daniele Focosi, Marco Tuccori, Fabrizio Maggi
Pageof 37